Using Near-Infrared Light to Better Understand Peripheral Artery Disease
Recruiting now
Conditions studied: Peripheral Artery Disease (PAD)
In brief
The goal of this study is to better understand how blood flows and how oxygen is utilized in the lower limbs of people who suffer from peripheral artery disease. This study will also assess how these factors affect treatment outcomes. Specific aims include: Aim 1: Utilize BB-NIR-DCS to differentiate PAD patients experiencing primary oxygen delivery limitations from those suffering from mitochondrial dysfunction. Aim 2: Test the efficacy of BB-NIR-DCS at predicting individual responses to vascular intervention.
Key facts
- Study ID
- NCT07313410
- Run by
- The University of Texas at Arlington
- People needed
- 120
- Starts
- 2025-11-01
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2026-01-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Cases, Aim 1
- 18 or older
- willing to participate under the conditions described in the informed consent form (ICF)
- eligible to sign the ICF
- established diagnosis of PAD confirmed by a physician
- able to comply with the study requirements
- Cases, Aim 2
- completed Aim 1
- Controls 1) asymptomatic, with no history or diagnosis of peripheral artery disease
You may not qualify if…
- Cases, Aim 1
- Ankle-Brachial Index >0.9 or <0.4
- isolated disease in aorta/iliac vessels
- unstable angina or myocardial infarction in past 12 months
- orthopedic or other physical limitations which would prevent data collection
- contraindications to MRI, including presence of a Pacemaker, presence of bone growth/ bone fusion stimulators, presence of tissue expander, presence of cochlear implants, unable to ambulate for 10 feet, receiving continuous Oxygen therapy, pregnancy, permanent Jewelry (screened using MRI safety screening form and verbal screening by MRI operator
- Cases, Aim 2
- unstable angina or myocardial infarction in past 12 months
- orthopedic or other physical limitations which would prevent data collection
- contraindications to MRI, including presence of a pacemaker, presence of bone growth/ bone fusion stimulators, presence of tissue expander, presence of cochlear implants, unable to ambulate for 10 feet, receiving continuous Oxygen therapy, pregnancy, permanent Jewelry (screened using MRI safety screening form and verbal screening by MRI operator).
- Controls 1) history of peripheral artery disease 2) overt cardiovascular disease (e.g. heart failure) 3) known pulmonary disease (excluding mild asthma) 4) current tobacco use 5) orthopedic or other physical limitations which would prevent data collection, 6) BP >150/90 mmHg at screening 7) contraindications to MRI, including presence of a pacemaker, presence of bone growth/ bone fusion stimulators, presence of tissue expander, presence of cochlear implants, unable to ambulate for 10 feet, receiving continuous Oxygen therapy, pregnancy, permanent Jewelry (screened using MRI safety screening form and verbal screening by MRI operator).
Where it is running
- University of Texas at Arlington — Arlington, Texas, United States (enrolling)
- University of Texas Arlington — Arlington, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.